|
|
Volumn 1, Issue 3, 2001, Pages 294-298
|
|
Fatigue in multiple sclerosis.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMANTADINE;
BENZHYDRYL DERIVATIVE;
CENTRAL STIMULANT AGENT;
METHYLPHENIDATE;
MODAFINIL;
PEMOLINE;
AUTOIMMUNE DISEASE;
BRAIN;
CASE MANAGEMENT;
CLINICAL TRIAL;
COMPUTER ASSISTED EMISSION TOMOGRAPHY;
CONTROLLED CLINICAL TRIAL;
CROSSOVER PROCEDURE;
DEPRESSION;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
FATIGUE;
HEAT;
HOSPITALIZATION;
HUMAN;
HYPOTHALAMUS;
METABOLISM;
MULTIMODALITY CANCER THERAPY;
MULTIPLE SCLEROSIS;
PATHOPHYSIOLOGY;
PATIENT CARE;
PHYSIOTHERAPY;
PILOT STUDY;
PSYCHOLOGICAL ASPECT;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SCINTISCANNING;
SELF EVALUATION;
AMANTADINE;
AUTOIMMUNE DISEASES;
BENZHYDRYL COMPOUNDS;
BRAIN;
CASE MANAGEMENT;
CENTRAL NERVOUS SYSTEM STIMULANTS;
COMBINED MODALITY THERAPY;
CROSS-OVER STUDIES;
DEPRESSION;
DOUBLE-BLIND METHOD;
FATIGUE;
HEAT;
HUMANS;
HYPOTHALAMUS;
METHYLPHENIDATE;
MULTIPLE SCLEROSIS;
PATIENT CARE TEAM;
PEMOLINE;
PHYSICAL THERAPY MODALITIES;
PILOT PROJECTS;
RANDOMIZED CONTROLLED TRIALS;
SELF ASSESSMENT (PSYCHOLOGY);
SEVERITY OF ILLNESS INDEX;
TOMOGRAPHY, EMISSION-COMPUTED;
|
|
EID: 0035352373
PISSN: 15284042
EISSN: None
Source Type: Journal
DOI: 10.1007/s11910-001-0033-7 Document Type: Review |
|
Times cited : (102)
|
|
References (49)
|
